semaglutide + tirzepatide vs How to choose between semaglutide

A proteomic signature was identified that robustly predicted semaglutide treatment status

Understanding why helps set realistic expectations and troubleshoot if results are not appearing on the expected timeline

These are real but modest results, especially compared to semaglutide results showing 15-20% body weight reduction

The Takeaway Questions remain about the long-term effectiveness and safety of GLP-1s, and payor coverage for these meds has been a challenge, but tirzepatides trial results and the huge momentum in the weight loss space suggest that obesity care is about to change in a major way

Susana Monereo subraya la importancia de iniciar el tratamiento del sobrepeso lo antes posible: "Un kilo de ms puede ser el principio de una larga batalla contra la obesidad"